Neuropsychopathological comorbidities in learning disorders

Learning Disorders (LD) are complex diseases that affect about 2-10% of the school-age population. We performed neuropsychological and psychopathological evaluation, in order to investigate comorbidity in children with LD. Our sample consisted of 448 patients from 7 to 16 years of age with a diagnos...

Full description

Saved in:
Bibliographic Details
Published in:BMC neurology 2013-12, Vol.13 (1), p.198-198, Article 198
Main Authors: Margari, Lucia, Buttiglione, Maura, Craig, Francesco, Cristella, Arcangelo, de Giambattista, Concetta, Matera, Emilia, Operto, Francesca, Simone, Marta
Format: Article
Language:English
Subjects:
Adolescent
Age
Chi-Square Distribution
Child
Cognition Disorders - epidemiology
Comorbidity
Complications and side effects
Development and progression
Developmental Disabilities - epidemiology
Female
Humans
Learning disabilities
Learning Disorders - epidemiology
Male
Medical research
Medicine, Experimental
Neuropsychological Tests
Prognosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Learning Disorders (LD) are complex diseases that affect about 2-10% of the school-age population. We performed neuropsychological and psychopathological evaluation, in order to investigate comorbidity in children with LD. Our sample consisted of 448 patients from 7 to 16 years of age with a diagnosis of LD, divided in two subgroups: Specific Learning Disorders (SLD), including reading, writing, mathematics disorders, and Learning Disorders Not Otherwise Specified (LD NOS). Comorbidity with neuropsychopathologies was found in 62.2% of the total sample. In the LSD subgroup, ADHD was present in 33%, Anxiety Disorder in 28.8%, Developmental Coordination Disorder in 17.8%, Language Disorder in 11% and Mood Disorder in 9.4% of patients. In LD NOS subgroup, Language Disorder was present in 28.6%, Developmental Coordination Disorder in 27.5%, ADHD in 25.4%, Anxiety Disorder in 16.4%, Mood Disorder in 2.1% of patients. A statistically significant presence was respectively found for Language and Developmental Coordination Disorder comorbidity in LD NOS and for ADHD, mood and anxiety disorder comorbidity in SLD subgroup. The different findings emerging in this study suggested to promote further investigations to better define the difference between SLD and LD NOS, in order to improve specific interventions to reduce the long range consequences.
ISSN:1471-2377
1471-2377
DOI:10.1186/1471-2377-13-198